PTC Therapeutics Inc. (PTCT)

43.02
0.97 2.21
NASDAQ : Health Technology
Prev Close 43.99
Open 43.98
Day Low/High 42.98 / 45.07
52 Wk Low/High 27.53 / 48.99
Volume 320.65K
Avg Volume 764.30K
Exchange NASDAQ
Shares Outstanding 58.43M
Market Cap 2.50B
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
EXPANDED CLASS PERIOD: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm

EXPANDED CLASS PERIOD: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against PTC Therapeutics, Inc.

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased PTC Therapeutics, Inc.

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

Why PTC Therapeutics (PTCT) Stock Is Spiking Today

Why PTC Therapeutics (PTCT) Stock Is Spiking Today

PTC Therapeutics (PTCT) stock is skyrocketing this afternoon after a U.K. regulator recommended its drug for a deadly muscle disease.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of PTC Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 2, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of PTC Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 2, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of PTC Therapeutics, Inc.

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased PTC Therapeutics, Inc.

Looking for Sunshine in Biotech's Gloomy First-Quarter Performance

Looking for Sunshine in Biotech's Gloomy First-Quarter Performance

The Nasdaq Biotechnology Index fell 23% in the first quarter. The last time the biotech index underperformed to this degree was in June 2002 when it lost 34%.

The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against PTC Therapeutics, Inc.

The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against PTC Therapeutics, Inc.

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.

STOCK NOTICE: Rosen Law Firm Reminds PTC Therapeutics, Inc. Investors Of Important Deadline In Class Action

STOCK NOTICE: Rosen Law Firm Reminds PTC Therapeutics, Inc. Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of PTC Therapeutics, Inc.

SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against PTC Therapeutics, Inc.

First Week Of May 20th Options Trading For PTC Therapeutics (PTCT)

First Week Of May 20th Options Trading For PTC Therapeutics (PTCT)

Investors in PTC Therapeutics Inc saw new options become available this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PTCT options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering big breakouts.

PTC Therapeutics (PTCT) In A Perilous Reversal

PTC Therapeutics (PTCT) In A Perilous Reversal

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

7 Breakout Stocks Spiking on Big Volume

7 Breakout Stocks Spiking on Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against PTC Therapeutics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against PTC Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of PTC Therapeutics, Inc.

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation Of PTC Therapeutics, Inc. And Urges Investors With Losses To Contact The Firm

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation Of PTC Therapeutics, Inc. And Urges Investors With Losses To Contact The Firm

Lundin Law PC announces it is investigating claims against PTC Therapeutics, Inc.

PTC Therapeutics (PTCT) Stock Price Cut at Credit Suisse

PTC Therapeutics (PTCT) Stock Price Cut at Credit Suisse

Credit Suisse reduced its price target on PTC Therapeutics (PTCT) stock and maintained its ‘outperform’ rating on Tuesday morning.

Germany Slaps PTC Therapeutics With Big Drug Price Cut

Germany Slaps PTC Therapeutics With Big Drug Price Cut

The reimbursed price of PTC Therapeutics' rare disease drug Translarna was reduced by 65% in a ruling on Thursday by a German insurance arbitration board.

Perilous Reversal Watch: PTC Therapeutics (PTCT)

Perilous Reversal Watch: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

PTC Therapeutics (PTCT) Stock Price Target Cut at Oppenheimer

PTC Therapeutics (PTCT) Stock Price Target Cut at Oppenheimer

Oppenheimer lowered its price target on PTC Therapeutics (PTCT) stock and reiterated its ‘outperform’ rating on Thursday morning.

Here’s Why PTC Therapeutics (PTCT) Stock is Down Today

Here’s Why PTC Therapeutics (PTCT) Stock is Down Today

PTC Therapeutics (PTCT) stock is continuing to drop on Wednesday morning after receiving an FDA ‘Refuse to File’ letter yesterday.

PTC Therapeutics (PTCT) Is Today's Dead Cat Bounce Stock

PTC Therapeutics (PTCT) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

PTC Therapeutics (PTCT) Stock Upgraded at Jefferies

PTC Therapeutics (PTCT) Stock Upgraded at Jefferies

Jefferies upgraded PTC Therapeutics (PTCT) stock, but lowered its price target on Wednesday.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PTC Therapeutics, Inc. - PTCT

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PTC Therapeutics, Inc. - PTCT

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PTC Therapeutics, Inc.

Noteworthy Tuesday Option Activity: PTCT, HSNI, CRAI

Noteworthy Tuesday Option Activity: PTCT, HSNI, CRAI

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in PTC Therapeutics Inc , where a total volume of 7,068 contracts has been traded thus far today, a contract volume which is representative of approximately 706,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 97.7% of PTCT's average daily trading volume over the past month, of 723,160 shares.

GPM Announces Investigation On Behalf Of PTC Therapeutics, Inc. Investors

GPM Announces Investigation On Behalf Of PTC Therapeutics, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of PTC Therapeutics, Inc.

SHAREHOLDER ALERT: Scott + Scott, LLP Investigating PTC Therapeutics (PTCT) For Possible Securities Fraud

SHAREHOLDER ALERT: Scott + Scott, LLP Investigating PTC Therapeutics (PTCT) For Possible Securities Fraud

Scott + Scott, Attorneys at Law, LLP has commenced an investigation of PTC Therapeutics, Inc.

TheStreet Quant Rating: D (Sell)